CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission

NCT00092508 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1725

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: OPC-6535
DRUG: Asacol®

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.